Janiczek Wealth Management, LLC Alkermes Plc. Transaction History
Janiczek Wealth Management, LLC
- $475 Million
- Q2 2024
A detailed history of Janiczek Wealth Management, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Janiczek Wealth Management, LLC holds 55 shares of ALKS stock, worth $1,721. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55
Previous 55
-0.0%
Holding current value
$1,721
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ALKS
# of Institutions
362Shares Held
181MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$911 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$594 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$407 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$396 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$288 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.14B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...